Repros Therapeutics, Inc. (RPRX) Reports Q2 Loss of $0.30
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $56.23 +2.82%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CGEH, NAKA, APOG, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q2 EPS of ($0.30), versus ($0.20) reported last year. Revenue for the quarter came in at $1 thousand, versus $53 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
- Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
